BioPharmCatalyst Adds Trial Insights™ to its Suite of Biotech Investing Tools
2024年7月11日 - 8:55PM
ビジネスワイヤ(英語)
Biotech investors now have on-demand insights into clinical
trial data that can improve investment decisions
BioPharmCatalyst (BPC), a division of Scientist.com, today
announced that members with an “Elite” and “Elite Plus”
subscription now get full access to Trial Insights, which curates
and enriches publicly available data from clinicaltrials.gov and
other data sources. Trial Insights creates filterable, customizable
dashboards on clinical trial status, sponsors and new medicines,
enabling investors to make smarter, data-driven decisions.
“The ability to track drugs throughout their development cycle
based on catalyst events not only drives biotech investor decision
making, but also helps scientists keep up to date with clinical
trials in their research areas,” stated John Gagliano, Senior
Director, BioPharmCatalyst. “The addition of Trial Insights
provides subscribers with real time insight into clinical trial
results that were previously difficult and time consuming to gather
through publicly available sources.”
BPC equips investors in the biotech and pharmaceutical
industries with a comprehensive suite of tools for making informed
investment decisions. These include an FDA calendar, a PDUFA
calendar, an earnings calendar, the latest IPO information and a
company’s cash database. With Trial Insights, Elite and Elite Plus
subscribers can closely monitor ongoing clinical trials being
conducted around the world in real time through their existing
account.
To access BioPharmCatalyst’s investing tools and start a free
trial, visit www.biopharmcatalyst.com. To learn more about Trial
Insights, visit www.biopharmcatalyst.com/trial-insights.
About Scientist.com
Scientist.com is the world's leading AI-enabled marketplace for
scientific research. The marketplace simplifies drug discovery
research, saving time and money and providing access to the latest
innovative tools and technologies. Scientist.com operates private
enterprise marketplaces for most of the world’s major
pharmaceutical companies, over 100 biotechnology companies and the
US National Institutes of Health (NIH).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240711495417/en/
Sean Preci +1 877-644-3044 marketing@scientist.com